Skip to content

BioCryst Pharmaceuticals BCRX Loss on lease termination

Loss on lease termination at other companies

TMC the metals company Inc. logo
TMC the metals company Inc.TMC
-$49.75K
First BanCorp logo
First BanCorpFBP
$125K+400%
RadNet logo
RadNetRDNT
$0+100%
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
$0
TMC the metals company Inc. logo
TMC the metals company Inc.TMC
-$49.75K
Laureate Education, Inc. logo
Laureate Education, Inc.LAUR
$90K-64.7%

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%

Returns & leverage

See full
Return on equity-882.8%
Debt / equity0.1×
Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LossOnContractTermination.

The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's loss on lease termination.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's loss on lease termination?
BioCryst Pharmaceuticals (BCRX) reported loss on lease termination of $110K in Q4 2023.
What does loss on lease termination mean?
This metric captures the financial impact of terminating a contractual agreement before its scheduled expiration. It typically includes penalties, write-offs of related assets, or settlement costs incurred to exit the arrangement. High values may indicate operational restructuring or a strategic shift in business partnerships.